Company Monitoring Page for Arqule

latest headlines for company on cafepharma

5 Speculative Biotech Stocks With Catalysts Pending: Revisited
Seeking Alpha
Wed, 07/17/13 - 12:42 pm
Tags:
NewLink Genetics, OncoSec Medical, Arqule, Raptor Pharmaceuticals, Zogenix
Encouraging Phase 1 data with lead compound, ARQ 092, to be presented at AACR
Yahoo
Mon, 04/1/13 - 10:58 am
Tags:
ARQ092, Daiichi Sankyo, Arqule, akt protein inhibitor, cancer
ArQule Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Thu, 03/14/13 - 10:49 am
Tags:
earnings, Arqule
ArQule enrolls first patient in Phase 3 trial for carcinoma candidate tivantinib
Yahoo/Fly on the Wall
Thu, 01/31/13 - 10:48 am
Tags:
Arqule, tivantinib, hepatocellular carcinoma
Latest Tivantinib Failure Hits ArQule Despite Its Irrelevance
Seeking Alpha
Tue, 01/15/13 - 11:39 am
Tags:
tivantinib, Arqule, colorectal cancer, Daiichi Sankyo
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 01/12/13 - 10:38 am
Tags:
Arqule, Sequenom, Idenix
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha
Mon, 12/24/12 - 10:44 am
Tags:
Arqule, Array Biopharma, Celldex, Aveo Pharmaceutical, Curis, Exelixis, MorphoSys, Genmab, Novartis, Incyte, Seattle Genetics, YM BioSciences
ArQule: An Inexpensive And Well-Financed Oncology Opportunity
Seeking Alpha
Thu, 12/13/12 - 04:29 pm
Tags:
Arqule, Daiichi Sankyo, ARQ-087
3 Biotechs With Good FDA News
Motley Fool
Wed, 10/17/12 - 11:49 am
Tags:
FDA, Arqule, Threshold Pharmaceuticals, Amarin
ArQule's Tivantinib Failure And Exelixis' Cabozantinib PDUFA: Is There A Correlation?
Seeking Alpha
Fri, 10/12/12 - 12:17 pm
Tags:
Arqule, tivantinib, Exelixis, cabozantinib, non-small cell lung cancer
Weekend Recap: Biotech Madness
Seeking Alpha
Sun, 10/7/12 - 11:47 am
Tags:
Sarepta Therapeutics, Synta Pharmaceuticals, Arena Pharmaceuticals, Arqule, Amarin, Acadia, Aeterna Zentaris
ArQule stock plunges as lung cancer study shelved
Yahoo/AP
Tue, 10/2/12 - 11:25 am
Tags:
Arqule, lung cancer, Daiichi Sankyo, tivantinib, non-small cell lung cancer
This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib
Motley Fool
Fri, 08/31/12 - 12:27 pm
Tags:
tivantinib, Arqule, lung cancer, Tarceva, Roche, Astellas
ArQule Shares Drop on Lung Cancer Drug Safety Concern
Minyanville
Wed, 08/29/12 - 12:17 pm
Tags:
Arqule, lung cancer, tivantinib
3 Innovative Biotech Stocks To Consider Today
Seeking Alpha
Mon, 08/13/12 - 01:36 pm
Tags:
Celgene, OncoSec, Onyx, Bayer, Arqule
Winners Of ASCO 2012
Seeking Alpha
Mon, 06/11/12 - 06:19 pm
Tags:
ASCO, Arqule, Array Biopharma, Astex, AstraZeneca, Bristol-Myers Squibb, GSK, Curis, Exelixis, Pfizer, Immunogen, Seattle Genetics, Sanofi, Synta
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3
Seeking Alpha
Mon, 05/28/12 - 11:21 am
Tags:
ASCO, Synta, Sunesis, Arqule, Cyclacel, Aveo, Bristol-Myers Squibb
22 Biopharma Stocks With Breakout Potential in 2012
Seeking Alpha
Tue, 05/22/12 - 11:25 am
Tags:
Ziopharm, Zalicus, EXACT Sciences, Geron, Lexicon Pharmaceuticals, Nektar, Vical, Celgene, Celsion, ChemoCentryx, Clovis Oncology, Eli Lilly, JNJ, Pfizer, Elan, Biomarin, Biogen Idec, Auxilium, Arqule, Anthera, Acadia, Amicus Therapeutics, Vertex Pharmaceuticals
ASCO '12 Abstract Dump: Cancer Stocks in Focus
TheStreet.com
Thu, 05/17/12 - 10:35 am
Tags:
ASCO, Array Biopharma, Exelixis, Pharmacyclics, Onyx, Seattle Genetics, Aveo, Ariad Pharmaceuticals, Arqule, Oncothyreon
Upcoming ASCO Meeting Could Move These Stocks
Seeking Alpha
Wed, 04/4/12 - 08:45 am
Tags:
ASCO, Allos, Ariad Pharmaceuticals, Arqule, Array Biopharma, ImmunoCellular Therapeutics, Exelixis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.